p18 Ink4c and Pten constrain a positive regulatory loop between cell growth and cell cycle control.

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Molecular and Cellular Biology

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16738322PMCID PMC1489117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Transcriptional regulation of AKT activation by E2F.

  2004cited by this paper
• The prevalence of pituitary adenomas

  2004cited by this paper
• Haploinsufficiency of p18INK4c Sensitizes Mice to Carcinogen-Induced Tumorigenesis

  2003cited by this paper
• Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer.

  2003cited by this paper
• Genetic interactions between Pten and p53 in radiation-induced lymphoma development

  2003cited by this paper
• Cooperativity of Nkx3.1 and Pten loss of function in a mouse model of prostate carcinogenesis

  2002cited by this paper
• The phosphoinositide 3-kinase pathway.

  2002cited by this paper
• Haplo-insufficiency? Let me count the ways.

  2001cited by this paper
• Loss of p16Ink4a with retention of p19Arf predisposes mice to tumorigenesis

  2001cited by this paper
• Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression

  2001cited by this paper
• Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice

  2001cited by this paper
• Wide spectrum of tumors in knock‐in mice carrying a Cdk4 protein insensitive to INK4 inhibitors

  2001cited by this paper
• Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse

  2001cited by this paper
• Accommodating haploinsufficient tumour suppressor genes in Knudson's model

  2000cited by this paper
• High incidence of breast and endometrial neoplasia resembling human Cowden syndrome in pten+/- mice.

  2000cited by this paper
• Molecular genetics of prostate cancer.

  2000cited by this paper
• Functional Collaboration between Different Cyclin-Dependent Kinase Inhibitors Suppresses Tumor Growth with Distinct Tissue Specificity

  2000cited by this paper
• Limited overlapping roles of P15INK4b and P18INK4c cell cycle inhibitors in proliferation and tumorigenesis

  2000cited by this paper
• Mutation of Pten/Mmac1 in mice causes neoplasia in multiple organ systems.

  1999cited by this paper
• Impaired Fas response and autoimmunity in Pten+/- mice.

  1999cited by this paper
• New insights into tumor suppression: PTEN suppresses tumor formation by restraining the phosphoinositide 3-kinase/AKT pathway.

  1999cited by this paper
• CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis.

  1998cited by this paper
• Pten is essential for embryonic development and tumour suppression

  1998cited by this paper
• The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate*

  1998cited by this paper
• Cancer Cell Cycles

  1996cited by this paper
• The retinoblastoma protein and cell cycle control.

  1995cited by this paper
• Developmental rescue of an embryonic‐lethal mutation in the retinoblastoma gene in chimeric mice.

  1994cited by this paper
• Cooperative tumorigenic effects of germline mutations in Rb and p53

  1994cited by this paper
• Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis

  1992cited by this paper
• Effects of an Rb mutation in the mouse

  1992cited by this paper
• Coordination of growth with cell division in the yeast Saccharomyces cerevisiae.

  1977cited by this paper
• Mutation and cancer: statistical study of retinoblastoma.

  1971cited by this paper

• High-salt diet induces immune-independent re-differentiation, metabolic shut down and cell cycle arrest of melanoma

  2025cites this paper
• CIP/KIP and INK4 families as hostages of oncogenic signaling

  2024cites this paper
• p18INK4C and BRCA1 inhibit follicular cell proliferation and dedifferentiation in thyroid cancer

  2023influential citation
• Insights into Mechanisms of Tumorigenesis in Neuroendocrine Neoplasms

  2021cites this paper
• Genetic analysis of the cooperative tumorigenic effects of targeted deletions of tumor suppressors Rb1, Trp53, Men1, and Pten in neuroendocrine tumors in mice

  2020cites this paper
• Cellular and Molecular Progression of Prostate Cancer: Models for Basic and Preclinical Research

  2020cites this paper
• Palbociclib has antitumour effects on Pten‐deficient endometrial neoplasias

  2017cites this paper
• Cell Cycle Control by PTEN.

  2017cites this paper
• Gata3 restrains B cell proliferation and cooperates with p18INK4c to repress B cell lymphomagenesis

  2016cites this paper
• Role of suppressor of cytokine signalling 1 (SOCS1) in the pathogenesis of prostate cancer

  2016cites this paper
• Role of CDKN2C Copy Number in Sporadic Medullary Thyroid Carcinoma

  2016cites this paper
• DNA methyltransferase 3A promotes cell proliferation by silencing CDK inhibitor p18INK4C in gastric carcinogenesis

  2015cites this paper
• Molecular genetic advances in pituitary tumor development

  2015cites this paper
• Cancer-associated PTEN mutants act in a dominant-negative manner to suppress PTEN protein function.

  2014cites this paper
• Long noncoding RNAs (lncRNAs) and the molecular hallmarks of aging

  2014cites this paper
• Cell cycle regulation by long non-coding RNAs

  2013cites this paper
• Germline mutation of Brca1 alters the fate of mammary luminal cells and causes luminal-to-basal mammary tumor transformation

  2013cites this paper
• The Role of MYC Rearrangements and Relative Copy Number Gain in Prostate Cancer

  2013cites this paper
• Trp53 inactivation leads to earlier phaeochromocytoma formation in pten knockout mice.

  2012cites this paper
• Murine Models and Cell Lines for the Investigation of Pheochromocytoma: Applications for Future Therapies?

  2012cites this paper
• Pharmacologie moléculaire du sunitinib et du vandetanib, deux inhibiteurs d’activité kinase, dans le cancer médullaire de la thyroïde

  2011cites this paper
• Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes.

  2011cites this paper
• Dual loss of rb1 and Trp53 in the adrenal medulla leads to spontaneous pheochromocytoma.

  2010cites this paper
• Cancer Biomarker Discovery: The Entropic Hallmark

  2010cites this paper
• Molecular genetics of prostate cancer: new prospects for old challenges.

  2010cites this paper
• From man to mouse and back again: advances in defining tumor AKTivities in vivo

  2010cites this paper
• P18 is a tumor suppressor gene involved in human medullary thyroid carcinoma and pheochromocytoma development

  2009cites this paper
• CDK inhibitor p18(INK4c) is a downstream target of GATA3 and restrains mammary luminal progenitor cell proliferation and tumorigenesis.

  2009cites this paper
• Expression levels of p18INK4C modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines

  2009cites this paper
• The Par-4/PTEN connection in tumor suppression

  2009cites this paper
• Expression levels of p 18 INK 4 C modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines

  2009cites this paper
• Simultaneous inactivation of Par-4 and PTEN in vivo leads to synergistic NF-κB activation and invasive prostate carcinoma

  2009cites this paper
• Expression of p18INK4C is Down-regulated in Human Pituitary Adenomas

  2009cites this paper
• Conditional Pten knock‐out mice: a model for metastatic phaeochromocytoma

  2009cites this paper
• Molecular genetics of medullary thyroid carcinoma: the quest for novel therapeutic targets.

  2009influential citation
• New targets and therapeutic approaches for endocrine malignancies.

  2009cites this paper
• Expression levels of p18 INK4C modify the cellular efficacy of cyclin-dependent kinase inhibitors via regulation of Mcl-1 expression in tumor cell lines

  2009cites this paper
• Phosphatase and tensin homologue and pituitary tumor-transforming gene in pituitary adenomas. Clinical-pathologic and immunohistochemical analysis.

  2008cites this paper
• Loss of the SSeCKS/Gravin/AKAP12 gene results in prostatic hyperplasia.

  2008cites this paper
• A small molecule disruptor of Rb/Raf-1 interaction inhibits cell proliferation, angiogenesis, and growth of human tumor xenografts in nude mice.

  2008cites this paper
• Conspirators in a capital crime: co-deletion of p18INK4c and p16INK4a/p14ARF/p15INK4b in glioblastoma multiforme.

  2008cites this paper
• Genetic modelling of the PTEN/AKT pathway in cancer research

  2008cites this paper
• PTEN: a new guardian of the genome

  2008cites this paper
• Identification of p18 INK4c as a tumor suppressor gene in glioblastoma multiforme.

  2008cites this paper
• New therapeutic approaches to treat medullary thyroid carcinoma

  2008cites this paper
• ErbB-2 Induces Bilateral Adrenal Pheochromocytoma Formation in Mice

  2007cites this paper
• Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 231 Molecular Genetic Studies of Sporadic and MEN 1-A ssociated Endocrine Pancreatic Tumors

  2007cites this paper
• Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.

  2007cites this paper